Get the Stockscreener App
13.16
0.08%
+0.010
Pre-market:
13.23
0.07
+0.53%
Takeda Pharmaceutical Co ADR stock is currently priced at $13.16, with a 24-hour trading volume of 1.29M.
It has seen a +0.08% increased in the last 24 hours and a -9.62% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $13.15 pivot point. If it approaches the $13.18 resistance level, significant changes may occur.
Takeda Pharmaceutical Co ADR Stock (TAK) Financials Data
Takeda Pharmaceutical Co ADR (TAK) Revenue 2024
TAK reported a revenue (TTM) of $29.70 billion for the quarter ending December 31, 2023, a -1.18% decline year-over-year.
Takeda Pharmaceutical Co ADR (TAK) Net Income 2024
TAK net income (TTM) was $1.27 billion for the quarter ending December 31, 2023, a -36.61% decrease year-over-year.
Takeda Pharmaceutical Co ADR (TAK) Cash Flow 2024
TAK recorded a free cash flow (TTM) of -$814.80 million for the quarter ending December 31, 2023, a -112.62% decrease year-over-year.
Takeda Pharmaceutical Co ADR (TAK) Earnings per Share 2024
TAK earnings per share (TTM) was $0.4014 for the quarter ending December 31, 2023, a -37.46% decline year-over-year.
Takeda Pharmaceutical Co ADR Stock (TAK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner |
Jan 24 '24 |
Sale |
8.10 |
3,703,703 |
29,999,994 |
3,755,583 |
Takeda Pharmaceutical Co ADR Stock (TAK) Latest News
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
Zacks Investment Research
Takeda Pharmaceutical Co. (TAK) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
TAK or STVN: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
Zacks Investment Research
Protagonist (PTGX) Up 14% on Licensing Deal With Takeda
Zacks Investment Research
One Ultra-Cheap High-Yield Dividend Stock to Buy
The Motley Fool
About Takeda Pharmaceutical Co ADR
Takeda Pharmaceutical Company Limited, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. The company provides medicines in various therapeutic areas comprising gastroenterology, oncology, and neuroscience; and vaccines. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, Asia, the Middle East, Oceania, and Africa. The company has a collaboration agreement with Lupus Therapeutics Inc. The company was founded in 1781 and is headquartered in Tokyo, Japan.
COMPANY PROFILE
NameTakeda Pharmaceutical Co ADR
SectorHealthcare (1194)
Industry
Webtakeda.com
Phone81 3 3278 2111
Employee27,230
Twitter
@takedapharma
SEC filings
Latest SEC Filings
Address1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo, Japan (103-8668)
0.25%
3.03%
Cap:
|
Volume (24h):